Liquidia Corp (LQDA)
12.79
-0.19
(-1.46%)
USD |
NASDAQ |
May 03, 16:00
12.78
0.00 (0.00%)
After-Hours: 20:00
Liquidia Cash from Operations (TTM): -41.56M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -41.56M |
September 30, 2023 | -30.18M |
June 30, 2023 | -24.40M |
March 31, 2023 | -27.26M |
December 31, 2022 | -28.59M |
September 30, 2022 | -31.54M |
June 30, 2022 | -31.60M |
March 31, 2022 | -31.43M |
December 31, 2021 | -34.04M |
September 30, 2021 | -40.56M |
June 30, 2021 | -47.24M |
March 31, 2021 | -52.09M |
December 31, 2020 | -54.14M |
Date | Value |
---|---|
September 30, 2020 | -54.12M |
June 30, 2020 | -53.56M |
March 31, 2020 | -52.61M |
December 31, 2019 | -48.28M |
September 30, 2019 | -42.55M |
June 30, 2019 | -36.88M |
March 31, 2019 | -31.94M |
December 31, 2018 | -31.83M |
September 30, 2018 | -28.16M |
June 30, 2018 | -27.14M |
March 31, 2018 | -25.25M |
December 31, 2017 | -24.29M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-54.14M
Minimum
Dec 2020
-24.40M
Maximum
Jun 2023
-40.14M
Average
-40.56M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
United Therapeutics Corp | 979.70M |
AIM ImmunoTech Inc | -21.27M |
Perspective Therapeutics Inc | -36.91M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |